Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See full details.
I Agree
×
Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Privacy Policy | Disclaimer

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Privacy Policy | Disclaimer
Please Try Again {{ error }}

Send my password

Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
News Focus
Voyageur Secures First International Sales Contract worth US$1.9 Million (click to learn more)
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

GTEC Holdings Ltd GGTTF

Healthcare Drug Manufacturers - Major
GTEC Holdings Ltd is a Canada based company. It is pursuing opportunities in the cannabis industry and has the goal to identify and consolidate licensed producers of ultra-premium cannabis under Health Canada's Cannabis Act and Regulations and vertically integrating its operations by pursuing cannabis retail sales where permissible across Canada.


GREY:GGTTF - Post by User

GTEC Holdings Ltd
<< Previous
 Bullboard Posts
Next >>
User Avatar Image
(23)
•••
Post by kijijion Apr 29, 2019 12:45pm
171 Views
Post# 29683969

projections

projectionsGTEC Holdings (OTCMKTS:GGTTF), a boutique premium cannabis firm based in British Columbia, has released sales projections based on initial demand seen in 2019 so far. The company is seeing an 81% gross profit margin and has secured forward agreements extending out to the remainder of the year. Production estimates are for about 2.5 million grams of flower in 2019 at an average sale price of $5.86 and cash cost of $1.11 per gram. 
<< Previous
 Bullboard Posts
Next >>
Dealroom for high-potential pre-IPO opportunities